Despite rising Medicare Advantage (MA) utilization, Elevance Health has come out of Q1 2025 unscathed. The company reported adjusted diluted earnings per share of $11.97 and stuck to its prediction of $34.15 to $34.85 adjusted earnings per share for 2025. This contrasts with peer UnitedHealth Group, which lowered its earnings predictions for the year in its call last week following a disappointing quarter. (Elevance released a preview of its earnings in a Form 8-K on April 17, hours after UnitedHealth detailed its surprisingly bad quarter, to reassure investors.) “We’re staying focused on what we can control, delivering operational results, engaging proactively with partners, and advancing our long-term strategy,” President and CEO Gail Boudreaux said in Elevance’s April 22 earnings call. United attributed its struggle to surprisingly high MA utilization and unexpected expenses from Optum, the company’s healthcare services business, Healthcare Brew previously reported. See more on Elevance’s earnings here.—CC |